

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.28372774 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.28372774 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.96853287 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.96853287 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.23642964 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.20472711 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 5.47682065 |
| 8 | bile acid biosynthetic process (GO:0006699) | 5.36961061 |
| 9 | sulfur amino acid catabolic process (GO:0000098) | 5.35204974 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.33145498 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 5.33145498 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 5.33145498 |
| 13 | cysteine metabolic process (GO:0006534) | 5.30613082 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.30116576 |
| 15 | negative regulation of fibrinolysis (GO:0051918) | 5.28236542 |
| 16 | urea metabolic process (GO:0019627) | 5.25620553 |
| 17 | urea cycle (GO:0000050) | 5.25620553 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.23033900 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.19949463 |
| 20 | serine family amino acid catabolic process (GO:0009071) | 5.12221709 |
| 21 | tryptophan metabolic process (GO:0006568) | 5.10007413 |
| 22 | complement activation, alternative pathway (GO:0006957) | 5.09058223 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.01798543 |
| 24 | regulation of protein activation cascade (GO:2000257) | 4.95945893 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.92966310 |
| 26 | protein carboxylation (GO:0018214) | 4.92966310 |
| 27 | regulation of triglyceride catabolic process (GO:0010896) | 4.85214379 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 4.84580562 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.75711548 |
| 30 | bile acid metabolic process (GO:0008206) | 4.73963149 |
| 31 | acylglycerol homeostasis (GO:0055090) | 4.71473543 |
| 32 | triglyceride homeostasis (GO:0070328) | 4.71473543 |
| 33 | plasma lipoprotein particle clearance (GO:0034381) | 4.67970437 |
| 34 | reverse cholesterol transport (GO:0043691) | 4.65454087 |
| 35 | homocysteine metabolic process (GO:0050667) | 4.64504782 |
| 36 | regulation of complement activation (GO:0030449) | 4.62831130 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 4.62551522 |
| 38 | aromatic amino acid family metabolic process (GO:0009072) | 4.62347619 |
| 39 | protein-lipid complex remodeling (GO:0034368) | 4.61519594 |
| 40 | macromolecular complex remodeling (GO:0034367) | 4.61519594 |
| 41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.61519594 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 4.57458743 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.51490969 |
| 44 | alpha-amino acid catabolic process (GO:1901606) | 4.46184637 |
| 45 | lysine metabolic process (GO:0006553) | 4.43534561 |
| 46 | lysine catabolic process (GO:0006554) | 4.43534561 |
| 47 | glycine metabolic process (GO:0006544) | 4.39823122 |
| 48 | low-density lipoprotein particle clearance (GO:0034383) | 4.33565585 |
| 49 | phospholipid efflux (GO:0033700) | 4.33522078 |
| 50 | protein-lipid complex subunit organization (GO:0071825) | 4.26643142 |
| 51 | diacylglycerol metabolic process (GO:0046339) | 4.26265308 |
| 52 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.22088016 |
| 53 | negative regulation of protein activation cascade (GO:2000258) | 4.20637826 |
| 54 | cellular amino acid catabolic process (GO:0009063) | 4.18330754 |
| 55 | serine family amino acid metabolic process (GO:0009069) | 4.16243877 |
| 56 | cellular ketone body metabolic process (GO:0046950) | 4.15500656 |
| 57 | negative regulation of cholesterol transport (GO:0032375) | 4.15206442 |
| 58 | negative regulation of sterol transport (GO:0032372) | 4.15206442 |
| 59 | coenzyme catabolic process (GO:0009109) | 4.05545015 |
| 60 | cholesterol efflux (GO:0033344) | 4.03821664 |
| 61 | bile acid and bile salt transport (GO:0015721) | 3.97369500 |
| 62 | positive regulation of lipid catabolic process (GO:0050996) | 3.96824574 |
| 63 | serine family amino acid biosynthetic process (GO:0009070) | 3.95392402 |
| 64 | plasma lipoprotein particle assembly (GO:0034377) | 3.94928777 |
| 65 | regulation of plasminogen activation (GO:0010755) | 3.92724791 |
| 66 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.89793730 |
| 67 | fatty acid beta-oxidation (GO:0006635) | 3.85204691 |
| 68 | acetyl-CoA metabolic process (GO:0006084) | 3.84361150 |
| 69 | acylglycerol catabolic process (GO:0046464) | 3.84171516 |
| 70 | neutral lipid catabolic process (GO:0046461) | 3.84171516 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 3.82579227 |
| 72 | organic acid catabolic process (GO:0016054) | 3.81938735 |
| 73 | carboxylic acid catabolic process (GO:0046395) | 3.81938735 |
| 74 | indolalkylamine metabolic process (GO:0006586) | 3.81238453 |
| 75 | imidazole-containing compound metabolic process (GO:0052803) | 3.80735968 |
| 76 | intestinal cholesterol absorption (GO:0030299) | 3.79555832 |
| 77 | short-chain fatty acid metabolic process (GO:0046459) | 3.78989038 |
| 78 | glutamate metabolic process (GO:0006536) | 3.78803416 |
| 79 | fatty acid oxidation (GO:0019395) | 3.78296607 |
| 80 | phospholipid homeostasis (GO:0055091) | 3.77558288 |
| 81 | cholesterol homeostasis (GO:0042632) | 3.72820596 |
| 82 | valine metabolic process (GO:0006573) | 3.72610544 |
| 83 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.71866205 |
| 84 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.71866205 |
| 85 | amine catabolic process (GO:0009310) | 3.70854343 |
| 86 | cellular biogenic amine catabolic process (GO:0042402) | 3.70854343 |
| 87 | lipid oxidation (GO:0034440) | 3.70305620 |
| 88 | low-density lipoprotein particle remodeling (GO:0034374) | 3.70170706 |
| 89 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.69228886 |
| 90 | fatty acid catabolic process (GO:0009062) | 3.68042116 |
| 91 | intestinal absorption (GO:0050892) | 3.67597964 |
| 92 | sterol homeostasis (GO:0055092) | 3.66829975 |
| 93 | monocarboxylic acid catabolic process (GO:0072329) | 3.66676572 |
| 94 | ethanol oxidation (GO:0006069) | 3.65682326 |
| 95 | negative regulation of lipase activity (GO:0060192) | 3.64210736 |
| 96 | fibrinolysis (GO:0042730) | 3.61996377 |
| 97 | cellular glucuronidation (GO:0052695) | 3.61772780 |
| 98 | benzene-containing compound metabolic process (GO:0042537) | 3.61601687 |
| 99 | regulation of cholesterol homeostasis (GO:2000188) | 3.61040943 |
| 100 | triglyceride catabolic process (GO:0019433) | 3.58893198 |
| 101 | ketone body metabolic process (GO:1902224) | 3.57674434 |
| 102 | plasma lipoprotein particle organization (GO:0071827) | 3.55843179 |
| 103 | regulation of bile acid biosynthetic process (GO:0070857) | 3.55456193 |
| 104 | arginine metabolic process (GO:0006525) | 3.53978533 |
| 105 | protein-lipid complex assembly (GO:0065005) | 3.52602583 |
| 106 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.52309999 |
| 107 | lipoprotein metabolic process (GO:0042157) | 3.52242732 |
| 108 | drug catabolic process (GO:0042737) | 3.51786284 |
| 109 | cholesterol transport (GO:0030301) | 3.50923135 |
| 110 | sterol transport (GO:0015918) | 3.50923135 |
| 111 | blood coagulation, intrinsic pathway (GO:0007597) | 3.49823654 |
| 112 | 2-oxoglutarate metabolic process (GO:0006103) | 3.49787111 |
| 113 | exogenous drug catabolic process (GO:0042738) | 3.36926954 |
| 114 | negative regulation of complement activation (GO:0045916) | 3.32073119 |
| 115 | peptidyl-glutamic acid modification (GO:0018200) | 3.30853171 |
| 116 | nephron tubule morphogenesis (GO:0072078) | 3.25910119 |
| 117 | nephron epithelium morphogenesis (GO:0072088) | 3.25910119 |
| 118 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.22885131 |
| 119 | transepithelial transport (GO:0070633) | 3.19020684 |
| 120 | lipid homeostasis (GO:0055088) | 3.16781702 |
| 121 | glycerolipid catabolic process (GO:0046503) | 3.12051788 |
| 122 | negative regulation of sodium ion transport (GO:0010766) | 3.10703724 |
| 123 | behavioral response to nicotine (GO:0035095) | 3.09488178 |
| 124 | regulation of apoptotic cell clearance (GO:2000425) | 3.08683863 |
| 125 | protein activation cascade (GO:0072376) | 3.07708974 |
| 126 | heme transport (GO:0015886) | 3.03438125 |
| 127 | regulation of humoral immune response (GO:0002920) | 2.97559152 |
| 128 | acute-phase response (GO:0006953) | 2.97440181 |
| 129 | epoxygenase P450 pathway (GO:0019373) | 2.96382638 |
| 130 | negative regulation of blood coagulation (GO:0030195) | 2.95183483 |
| 131 | negative regulation of hemostasis (GO:1900047) | 2.95183483 |
| 132 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.90510149 |
| 133 | positive regulation of lipid storage (GO:0010884) | 2.89579167 |
| 134 | ethanol metabolic process (GO:0006067) | 2.88334534 |
| 135 | fatty acid homeostasis (GO:0055089) | 2.86186448 |
| 136 | peristalsis (GO:0030432) | 2.86151239 |
| 137 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.84387057 |
| 138 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.84387057 |
| 139 | S-adenosylmethionine metabolic process (GO:0046500) | 2.81843346 |
| 140 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.78879342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.06035905 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.96286836 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.44050092 |
| 4 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.39098844 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.28830450 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.11578525 |
| 7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.07929349 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.01046335 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.76556795 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.19573460 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.93713661 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.80361515 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.40801036 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.15673526 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.11962802 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.03010040 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.3284367 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.97128789 |
| 19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.95763085 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.90014604 |
| 21 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.69747158 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.67795205 |
| 23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.60177805 |
| 24 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.52861526 |
| 25 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.50111167 |
| 26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.48398873 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.47474223 |
| 28 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.42697779 |
| 29 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41219018 |
| 30 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.39777226 |
| 31 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.37675476 |
| 32 | * ERA_21632823_ChIP-Seq_H3396_Human | 1.37303208 |
| 33 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.36785220 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35334972 |
| 35 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.34624496 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.32879151 |
| 37 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.30971627 |
| 38 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30653204 |
| 39 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.30107154 |
| 40 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.29733735 |
| 41 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.28705358 |
| 42 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.28088972 |
| 43 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.26869968 |
| 44 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.25236229 |
| 45 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.24422492 |
| 46 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.24203534 |
| 47 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.22935893 |
| 48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.18741058 |
| 49 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17151288 |
| 50 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.17039696 |
| 51 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.17039696 |
| 52 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.16726017 |
| 53 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.13680891 |
| 54 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11025647 |
| 55 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.10263647 |
| 56 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.10263647 |
| 57 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09812162 |
| 58 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.09521460 |
| 59 | NCOR_22424771_ChIP-Seq_293T_Human | 1.08939231 |
| 60 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.08865917 |
| 61 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07380857 |
| 62 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.07298518 |
| 63 | P300_19829295_ChIP-Seq_ESCs_Human | 1.06391231 |
| 64 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05859841 |
| 65 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.05776243 |
| 66 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04882928 |
| 67 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.03462324 |
| 68 | EWS_26573619_Chip-Seq_HEK293_Human | 1.03261873 |
| 69 | FUS_26573619_Chip-Seq_HEK293_Human | 1.02085471 |
| 70 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.02081621 |
| 71 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.01728017 |
| 72 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.99356380 |
| 73 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.99177748 |
| 74 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.99081374 |
| 75 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.98624858 |
| 76 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.97947198 |
| 77 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.97032525 |
| 78 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.96423427 |
| 79 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.95233527 |
| 80 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.94922519 |
| 81 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.94549135 |
| 82 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92406758 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91821502 |
| 84 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91013689 |
| 85 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.90993877 |
| 86 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.90868258 |
| 87 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89962827 |
| 88 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.89886309 |
| 89 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.89474148 |
| 90 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.89252717 |
| 91 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89220208 |
| 92 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.87049921 |
| 93 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.86907462 |
| 94 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.85958183 |
| 95 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.85446739 |
| 96 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.84911786 |
| 97 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.84911786 |
| 98 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84551772 |
| 99 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.84043283 |
| 100 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.83684468 |
| 101 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.82678919 |
| 102 | AR_25329375_ChIP-Seq_VCAP_Human | 0.82566747 |
| 103 | TCF4_23295773_ChIP-Seq_U87_Human | 0.82181217 |
| 104 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.81314893 |
| 105 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.81225809 |
| 106 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.81161731 |
| 107 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81083209 |
| 108 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.79744995 |
| 109 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.79702336 |
| 110 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78809546 |
| 111 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.78528443 |
| 112 | RXR_22108803_ChIP-Seq_LS180_Human | 0.78148790 |
| 113 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.77938182 |
| 114 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.77684133 |
| 115 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.77156683 |
| 116 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.76768403 |
| 117 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75979506 |
| 118 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.73455327 |
| 119 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.72397372 |
| 120 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.71009562 |
| 121 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.69967058 |
| 122 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.68868566 |
| 123 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66508388 |
| 124 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.65159581 |
| 125 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.64334620 |
| 126 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64156075 |
| 127 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59490701 |
| 128 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.59225366 |
| 129 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.57227287 |
| 130 | AR_20517297_ChIP-Seq_VCAP_Human | 0.56839446 |
| 131 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.56475403 |
| 132 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.55889823 |
| 133 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.55172339 |
| 134 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.53319237 |
| 135 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.51858711 |
| 136 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.50907214 |
| 137 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.50517238 |
| 138 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49486969 |
| 139 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48729439 |
| 140 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.46357654 |
| 141 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.45971381 |
| 142 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.45899063 |
| 143 | GATA1_19941826_ChIP-Seq_K562_Human | 0.45092669 |
| 144 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.44373256 |
| 145 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.44003214 |
| 146 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.43876982 |
| 147 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.43524632 |
| 148 | CBP_21632823_ChIP-Seq_H3396_Human | 0.42748066 |
| 149 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42697727 |
| 150 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.42395244 |
| 151 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.42198329 |
| 152 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.42198329 |
| 153 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.41586169 |
| 154 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.40844413 |
| 155 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.40612744 |
| 156 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.39214742 |
| 157 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.38746086 |
| 158 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.38489812 |
| 159 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.38308415 |
| 160 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.38105826 |
| 161 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38033698 |
| 162 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.37976599 |
| 163 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.37932695 |
| 164 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.37659621 |
| 165 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.35860038 |
| 166 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.35689055 |
| 167 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.35383284 |
| 168 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.34080947 |
| 169 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.33864464 |
| 170 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.33599653 |
| 171 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.33052925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.81188778 |
| 2 | MP0005360_urolithiasis | 6.94780828 |
| 3 | * MP0005365_abnormal_bile_salt | 6.15196779 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 6.02163688 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.43155234 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.03593614 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.80332622 |
| 8 | MP0003252_abnormal_bile_duct | 3.54191946 |
| 9 | MP0009840_abnormal_foam_cell | 3.17097791 |
| 10 | MP0003195_calcinosis | 3.14973872 |
| 11 | MP0005083_abnormal_biliary_tract | 3.11367492 |
| 12 | MP0003122_maternal_imprinting | 3.05462001 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.87579418 |
| 14 | MP0005332_abnormal_amino_acid | 2.84606668 |
| 15 | MP0002118_abnormal_lipid_homeostasis | 2.34807431 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.32338548 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.28388145 |
| 18 | MP0001986_abnormal_taste_sensitivity | 2.26305980 |
| 19 | * MP0000609_abnormal_liver_physiology | 2.23871506 |
| 20 | MP0005670_abnormal_white_adipose | 2.10675570 |
| 21 | MP0003136_yellow_coat_color | 2.05238387 |
| 22 | MP0001764_abnormal_homeostasis | 1.89650574 |
| 23 | MP0005551_abnormal_eye_electrophysiolog | 1.88788088 |
| 24 | MP0003868_abnormal_feces_composition | 1.86883287 |
| 25 | MP0002638_abnormal_pupillary_reflex | 1.83605428 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.82152720 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.80158613 |
| 28 | MP0005167_abnormal_blood-brain_barrier | 1.62933501 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.48771302 |
| 30 | MP0009697_abnormal_copulation | 1.48614770 |
| 31 | MP0003186_abnormal_redox_activity | 1.42713202 |
| 32 | MP0009643_abnormal_urine_homeostasis | 1.40197168 |
| 33 | MP0004130_abnormal_muscle_cell | 1.39349079 |
| 34 | MP0005451_abnormal_body_composition | 1.31861520 |
| 35 | MP0005666_abnormal_adipose_tissue | 1.24245312 |
| 36 | MP0002971_abnormal_brown_adipose | 1.24030577 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.23873069 |
| 38 | MP0005220_abnormal_exocrine_pancreas | 1.23387593 |
| 39 | MP0009780_abnormal_chondrocyte_physiolo | 1.21493316 |
| 40 | MP0002938_white_spotting | 1.20866556 |
| 41 | MP0000598_abnormal_liver_morphology | 1.19817625 |
| 42 | MP0002078_abnormal_glucose_homeostasis | 1.15158816 |
| 43 | MP0003011_delayed_dark_adaptation | 1.15156750 |
| 44 | MP0002876_abnormal_thyroid_physiology | 1.13281541 |
| 45 | MP0003123_paternal_imprinting | 1.11360758 |
| 46 | MP0003656_abnormal_erythrocyte_physiolo | 1.10363003 |
| 47 | MP0001661_extended_life_span | 1.08701056 |
| 48 | MP0000013_abnormal_adipose_tissue | 1.07914831 |
| 49 | MP0006036_abnormal_mitochondrial_physio | 1.06090971 |
| 50 | MP0002837_dystrophic_cardiac_calcinosis | 1.05063191 |
| 51 | MP0005334_abnormal_fat_pad | 1.04486369 |
| 52 | MP0002160_abnormal_reproductive_system | 1.03783586 |
| 53 | MP0000566_synostosis | 1.03362460 |
| 54 | MP0003121_genomic_imprinting | 1.00492616 |
| 55 | MP0005636_abnormal_mineral_homeostasis | 1.00347932 |
| 56 | MP0004133_heterotaxia | 0.97475236 |
| 57 | MP0005410_abnormal_fertilization | 0.97109526 |
| 58 | MP0005647_abnormal_sex_gland | 0.96612991 |
| 59 | MP0001324_abnormal_eye_pigmentation | 0.95761682 |
| 60 | MP0001756_abnormal_urination | 0.95735825 |
| 61 | MP0002254_reproductive_system_inflammat | 0.95673943 |
| 62 | MP0008872_abnormal_physiological_respon | 0.95347829 |
| 63 | MP0005535_abnormal_body_temperature | 0.95300831 |
| 64 | MP0001968_abnormal_touch/_nociception | 0.94447100 |
| 65 | MP0009763_increased_sensitivity_to | 0.93713562 |
| 66 | MP0005408_hypopigmentation | 0.93623719 |
| 67 | MP0000604_amyloidosis | 0.92947749 |
| 68 | MP0005375_adipose_tissue_phenotype | 0.90887905 |
| 69 | MP0005174_abnormal_tail_pigmentation | 0.90441142 |
| 70 | MP0004185_abnormal_adipocyte_glucose | 0.89561607 |
| 71 | MP0009642_abnormal_blood_homeostasis | 0.89220025 |
| 72 | MP0005448_abnormal_energy_balance | 0.88655068 |
| 73 | MP0002089_abnormal_postnatal_growth/wei | 0.87951743 |
| 74 | MP0005646_abnormal_pituitary_gland | 0.87568009 |
| 75 | MP0004142_abnormal_muscle_tone | 0.87089841 |
| 76 | MP0005376_homeostasis/metabolism_phenot | 0.82719191 |
| 77 | MP0008469_abnormal_protein_level | 0.79893649 |
| 78 | MP0004264_abnormal_extraembryonic_tissu | 0.78170077 |
| 79 | MP0005377_hearing/vestibular/ear_phenot | 0.76786270 |
| 80 | MP0003878_abnormal_ear_physiology | 0.76786270 |
| 81 | MP0000003_abnormal_adipose_tissue | 0.75146983 |
| 82 | MP0010368_abnormal_lymphatic_system | 0.74387127 |
| 83 | MP0003959_abnormal_lean_body | 0.73664242 |
| 84 | MP0003879_abnormal_hair_cell | 0.72965169 |
| 85 | MP0009764_decreased_sensitivity_to | 0.72558728 |
| 86 | MP0001270_distended_abdomen | 0.71755069 |
| 87 | MP0005195_abnormal_posterior_eye | 0.70892266 |
| 88 | MP0000639_abnormal_adrenal_gland | 0.70128760 |
| 89 | MP0009115_abnormal_fat_cell | 0.69738086 |
| 90 | MP0002970_abnormal_white_adipose | 0.69297101 |
| 91 | MP0005266_abnormal_metabolism | 0.68866839 |
| 92 | MP0005389_reproductive_system_phenotype | 0.68564214 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.66481276 |
| 94 | MP0003953_abnormal_hormone_level | 0.65600681 |
| 95 | MP0003567_abnormal_fetal_cardiomyocyte | 0.65456806 |
| 96 | MP0002933_joint_inflammation | 0.65368064 |
| 97 | MP0001501_abnormal_sleep_pattern | 0.64824700 |
| 98 | MP0010386_abnormal_urinary_bladder | 0.62953240 |
| 99 | MP0003718_maternal_effect | 0.62645303 |
| 100 | MP0005395_other_phenotype | 0.61453407 |
| 101 | MP0001944_abnormal_pancreas_morphology | 0.61408300 |
| 102 | MP0003690_abnormal_glial_cell | 0.61131202 |
| 103 | MP0009046_muscle_twitch | 0.61037897 |
| 104 | MP0003890_abnormal_embryonic-extraembry | 0.60907223 |
| 105 | MP0002132_abnormal_respiratory_system | 0.60806129 |
| 106 | MP0003950_abnormal_plasma_membrane | 0.60107764 |
| 107 | MP0003632_abnormal_nervous_system | 0.59823965 |
| 108 | MP0005253_abnormal_eye_physiology | 0.59672901 |
| 109 | MP0002557_abnormal_social/conspecific_i | 0.58927597 |
| 110 | MP0008877_abnormal_DNA_methylation | 0.58386776 |
| 111 | * MP0005084_abnormal_gallbladder_morpholo | 0.58108435 |
| 112 | MP0000538_abnormal_urinary_bladder | 0.57847659 |
| 113 | MP0006035_abnormal_mitochondrial_morpho | 0.57729103 |
| 114 | MP0005379_endocrine/exocrine_gland_phen | 0.57363018 |
| 115 | MP0003646_muscle_fatigue | 0.56651208 |
| 116 | MP0006292_abnormal_olfactory_placode | 0.56577498 |
| 117 | MP0009672_abnormal_birth_weight | 0.56542080 |
| 118 | MP0006276_abnormal_autonomic_nervous | 0.56537274 |
| 119 | MP0001502_abnormal_circadian_rhythm | 0.56189217 |
| 120 | MP0003329_amyloid_beta_deposits | 0.54107095 |
| 121 | MP0002136_abnormal_kidney_physiology | 0.49926059 |
| 122 | MP0005058_abnormal_lysosome_morphology | 0.49459165 |
| 123 | MP0004782_abnormal_surfactant_physiolog | 0.44270976 |
| 124 | MP0005452_abnormal_adipose_tissue | 0.43889505 |
| 125 | MP0003638_abnormal_response/metabolism_ | 0.43595025 |
| 126 | MP0002168_other_aberrant_phenotype | 0.42664374 |
| 127 | MP0009053_abnormal_anal_canal | 0.41167869 |
| 128 | MP0002796_impaired_skin_barrier | 0.40702040 |
| 129 | MP0003724_increased_susceptibility_to | 0.40253037 |
| 130 | MP0001881_abnormal_mammary_gland | 0.38818858 |
| 131 | MP0002928_abnormal_bile_duct | 0.37064496 |
| 132 | MP0000230_abnormal_systemic_arterial | 0.37046442 |
| 133 | MP0002060_abnormal_skin_morphology | 0.35340777 |
| 134 | MP0004043_abnormal_pH_regulation | 0.34660394 |
| 135 | MP0002909_abnormal_adrenal_gland | 0.34497323 |
| 136 | MP0002693_abnormal_pancreas_physiology | 0.34475613 |
| 137 | MP0002269_muscular_atrophy | 0.32271418 |
| 138 | MP0005464_abnormal_platelet_physiology | 0.32026076 |
| 139 | MP0010234_abnormal_vibrissa_follicle | 0.30146209 |
| 140 | MP0008438_abnormal_cutaneous_collagen | 0.29964082 |
| 141 | MP0008873_increased_physiological_sensi | 0.28746576 |
| 142 | MP0009384_cardiac_valve_regurgitation | 0.27660870 |
| 143 | MP0001243_abnormal_dermal_layer | 0.26170168 |
| 144 | MP0005164_abnormal_response_to | 0.25303666 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.08396989 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.65364503 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.64750235 |
| 4 | Xanthomatosis (HP:0000991) | 6.14156989 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.92606784 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.91914989 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.91040743 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.30643047 |
| 9 | Hypoglycemic coma (HP:0001325) | 5.07082135 |
| 10 | Complement deficiency (HP:0004431) | 5.02532852 |
| 11 | Hyperglycinemia (HP:0002154) | 4.95422863 |
| 12 | Hyperglycinuria (HP:0003108) | 4.81488388 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.70611679 |
| 14 | Hyperammonemia (HP:0001987) | 4.68022795 |
| 15 | Ketosis (HP:0001946) | 4.62571895 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 4.54935682 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.54935682 |
| 18 | Epidermoid cyst (HP:0200040) | 4.46654265 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.39087849 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 4.27715536 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 4.25356786 |
| 22 | Joint hemorrhage (HP:0005261) | 4.23338537 |
| 23 | Abnormality of the intrinsic pathway (HP:0010989) | 3.93383058 |
| 24 | Fat malabsorption (HP:0002630) | 3.92997325 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.90959991 |
| 26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.90519315 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 3.89929668 |
| 28 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.85745817 |
| 29 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.81891555 |
| 30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.81422456 |
| 31 | Ketoacidosis (HP:0001993) | 3.71966488 |
| 32 | Abnormality of complement system (HP:0005339) | 3.62832355 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.60271974 |
| 34 | Conjugated hyperbilirubinemia (HP:0002908) | 3.56846693 |
| 35 | Hypoglycemic seizures (HP:0002173) | 3.45612178 |
| 36 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.35673320 |
| 37 | Abnormality of serum amino acid levels (HP:0003112) | 3.31625224 |
| 38 | Hypophosphatemic rickets (HP:0004912) | 3.24982988 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.13506122 |
| 40 | Abnormality of alanine metabolism (HP:0010916) | 3.11080307 |
| 41 | Hyperalaninemia (HP:0003348) | 3.11080307 |
| 42 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.11080307 |
| 43 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.03816037 |
| 44 | Myocardial infarction (HP:0001658) | 2.99433101 |
| 45 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.98950979 |
| 46 | Dicarboxylic aciduria (HP:0003215) | 2.98950979 |
| 47 | Skin nodule (HP:0200036) | 2.95890665 |
| 48 | Hyperglycemia (HP:0003074) | 2.93498434 |
| 49 | Abnormality of nucleobase metabolism (HP:0010932) | 2.89688603 |
| 50 | Steatorrhea (HP:0002570) | 2.84807354 |
| 51 | Delayed CNS myelination (HP:0002188) | 2.81683858 |
| 52 | Lethargy (HP:0001254) | 2.80903042 |
| 53 | Gout (HP:0001997) | 2.74546306 |
| 54 | Congenital stationary night blindness (HP:0007642) | 2.73981037 |
| 55 | Metabolic acidosis (HP:0001942) | 2.73203901 |
| 56 | Hepatocellular carcinoma (HP:0001402) | 2.69672561 |
| 57 | Arthropathy (HP:0003040) | 2.68356092 |
| 58 | Abnormality of purine metabolism (HP:0004352) | 2.66696244 |
| 59 | Spontaneous abortion (HP:0005268) | 2.62877390 |
| 60 | Acanthocytosis (HP:0001927) | 2.52895209 |
| 61 | Hypochromic microcytic anemia (HP:0004840) | 2.51754449 |
| 62 | Hypothermia (HP:0002045) | 2.49570372 |
| 63 | Pigmentary retinal degeneration (HP:0001146) | 2.48879971 |
| 64 | Attenuation of retinal blood vessels (HP:0007843) | 2.48842327 |
| 65 | Irritability (HP:0000737) | 2.47802069 |
| 66 | Late onset (HP:0003584) | 2.47743796 |
| 67 | Abnormality of the nasal septum (HP:0000419) | 2.47673499 |
| 68 | Cerebral edema (HP:0002181) | 2.46630794 |
| 69 | Vaginal fistula (HP:0004320) | 2.46598976 |
| 70 | Pancreatitis (HP:0001733) | 2.42892414 |
| 71 | Brushfield spots (HP:0001088) | 2.40976506 |
| 72 | Potter facies (HP:0002009) | 2.40742039 |
| 73 | Facial shape deformation (HP:0011334) | 2.40742039 |
| 74 | Systemic lupus erythematosus (HP:0002725) | 2.40186768 |
| 75 | Symptomatic seizures (HP:0011145) | 2.34552256 |
| 76 | Generalized aminoaciduria (HP:0002909) | 2.34413036 |
| 77 | Glycosuria (HP:0003076) | 2.32194324 |
| 78 | Abnormality of urine glucose concentration (HP:0011016) | 2.32194324 |
| 79 | Abnormal gallbladder morphology (HP:0012437) | 2.28553327 |
| 80 | Glomerulonephritis (HP:0000099) | 2.19714037 |
| 81 | Rickets (HP:0002748) | 2.16296534 |
| 82 | Retinal atrophy (HP:0001105) | 2.16172566 |
| 83 | Spastic diplegia (HP:0001264) | 2.16105051 |
| 84 | Enlarged kidneys (HP:0000105) | 2.15941585 |
| 85 | Proximal tubulopathy (HP:0000114) | 2.15304878 |
| 86 | Abnormal urine output (HP:0012590) | 2.13953578 |
| 87 | Decreased central vision (HP:0007663) | 2.13547519 |
| 88 | Hypertriglyceridemia (HP:0002155) | 2.12336762 |
| 89 | Vomiting (HP:0002013) | 2.10950750 |
| 90 | Bile duct proliferation (HP:0001408) | 2.10187207 |
| 91 | Abnormal biliary tract physiology (HP:0012439) | 2.10187207 |
| 92 | Abnormality of proline metabolism (HP:0010907) | 2.09627164 |
| 93 | Hydroxyprolinuria (HP:0003080) | 2.09627164 |
| 94 | Cholelithiasis (HP:0001081) | 2.09136846 |
| 95 | Broad alveolar ridges (HP:0000187) | 2.08923112 |
| 96 | Mitral stenosis (HP:0001718) | 2.07816692 |
| 97 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.07703728 |
| 98 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.07703728 |
| 99 | Amyloidosis (HP:0011034) | 2.07220466 |
| 100 | Hemorrhage of the eye (HP:0011885) | 2.06890125 |
| 101 | Abnormal cartilage morphology (HP:0002763) | 2.06666797 |
| 102 | Esophageal varix (HP:0002040) | 2.06363270 |
| 103 | Vascular calcification (HP:0004934) | 2.06077600 |
| 104 | Pendular nystagmus (HP:0012043) | 2.06036258 |
| 105 | Mesangial abnormality (HP:0001966) | 2.05697829 |
| 106 | Abnormality of vitamin metabolism (HP:0100508) | 2.04126254 |
| 107 | Rectal fistula (HP:0100590) | 2.03332618 |
| 108 | Rectovaginal fistula (HP:0000143) | 2.03332618 |
| 109 | Abnormality of the renal cortex (HP:0011035) | 2.03069045 |
| 110 | Renal cortical cysts (HP:0000803) | 2.02660854 |
| 111 | Neonatal onset (HP:0003623) | 2.02133794 |
| 112 | Sensorimotor neuropathy (HP:0007141) | 2.00353013 |
| 113 | Chorioretinal atrophy (HP:0000533) | 2.00151526 |
| 114 | Nausea (HP:0002018) | 1.98485117 |
| 115 | Chronic hepatic failure (HP:0100626) | 1.98242176 |
| 116 | Osteomalacia (HP:0002749) | 1.96859990 |
| 117 | Widely patent fontanelles and sutures (HP:0004492) | 1.95615188 |
| 118 | Decreased circulating renin level (HP:0003351) | 1.94992819 |
| 119 | Polydipsia (HP:0001959) | 1.94462810 |
| 120 | Abnormal drinking behavior (HP:0030082) | 1.94462810 |
| 121 | Fair hair (HP:0002286) | 1.94357357 |
| 122 | Malnutrition (HP:0004395) | 1.93344511 |
| 123 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.92499867 |
| 124 | Opisthotonus (HP:0002179) | 1.91658527 |
| 125 | Abnormality of the vitreous humor (HP:0004327) | 1.91622589 |
| 126 | Tubular atrophy (HP:0000092) | 1.89999260 |
| 127 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.86392456 |
| 128 | Epiphyseal stippling (HP:0010655) | 1.86362635 |
| 129 | Increased purine levels (HP:0004368) | 1.84454373 |
| 130 | Hyperuricemia (HP:0002149) | 1.84454373 |
| 131 | Poikilocytosis (HP:0004447) | 1.84185688 |
| 132 | Cardiovascular calcification (HP:0011915) | 1.82730949 |
| 133 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82285858 |
| 134 | Pancreatic cysts (HP:0001737) | 1.81730814 |
| 135 | Elevated hepatic transaminases (HP:0002910) | 1.79617646 |
| 136 | Abnormality of the gallbladder (HP:0005264) | 1.79213307 |
| 137 | Menorrhagia (HP:0000132) | 1.78716899 |
| 138 | Gingival bleeding (HP:0000225) | 1.78536349 |
| 139 | Abnormality of renal excretion (HP:0011036) | 1.77882143 |
| 140 | Abnormal gallbladder physiology (HP:0012438) | 1.76649947 |
| 141 | Nephritis (HP:0000123) | 1.76142935 |
| 142 | Abolished electroretinogram (ERG) (HP:0000550) | 1.73476187 |
| 143 | Intestinal fistula (HP:0100819) | 1.71485148 |
| 144 | Supernumerary spleens (HP:0009799) | 1.71447611 |
| 145 | Molar tooth sign on MRI (HP:0002419) | 1.71413585 |
| 146 | Abnormality of midbrain morphology (HP:0002418) | 1.71413585 |
| 147 | Hyperphosphaturia (HP:0003109) | 1.70610453 |
| 148 | Thrombophlebitis (HP:0004418) | 1.69819508 |
| 149 | Abnormality of the wing of the ilium (HP:0011867) | 1.69034740 |
| 150 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.68159233 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.35738313 |
| 2 | SIK1 | 4.17988830 |
| 3 | ERN1 | 3.89825874 |
| 4 | FGFR4 | 3.68806836 |
| 5 | INSRR | 3.51264395 |
| 6 | WNK3 | 3.21404292 |
| 7 | PIK3CG | 3.16648162 |
| 8 | ZAK | 2.90762956 |
| 9 | ADRBK2 | 2.82469937 |
| 10 | MAPK15 | 2.78795382 |
| 11 | BMPR1B | 2.67071952 |
| 12 | TAOK3 | 2.56319580 |
| 13 | TLK1 | 2.55672033 |
| 14 | TRIB3 | 2.51975625 |
| 15 | ERBB4 | 2.23358379 |
| 16 | FRK | 2.03853382 |
| 17 | PIK3CA | 1.99917731 |
| 18 | CAMK1D | 1.99660097 |
| 19 | STK39 | 1.96435138 |
| 20 | MST1R | 1.91049299 |
| 21 | MAP4K2 | 1.86648847 |
| 22 | LATS1 | 1.67325746 |
| 23 | PKN2 | 1.62503558 |
| 24 | CAMKK2 | 1.61607279 |
| 25 | FLT3 | 1.60515897 |
| 26 | MAPK11 | 1.59549335 |
| 27 | TYRO3 | 1.41679378 |
| 28 | MAP2K4 | 1.40357596 |
| 29 | WNK1 | 1.39802503 |
| 30 | STK38L | 1.39539449 |
| 31 | PRKAA2 | 1.39360258 |
| 32 | PINK1 | 1.34808462 |
| 33 | CASK | 1.30978399 |
| 34 | PDK3 | 1.25664394 |
| 35 | PDK4 | 1.25664394 |
| 36 | DAPK2 | 1.24051119 |
| 37 | NEK9 | 1.23934434 |
| 38 | NUAK1 | 1.18041689 |
| 39 | NEK2 | 1.15053814 |
| 40 | ADRBK1 | 1.10937232 |
| 41 | PTK6 | 1.09437777 |
| 42 | ABL2 | 1.09126266 |
| 43 | SIK2 | 1.08979933 |
| 44 | IRAK3 | 1.07961259 |
| 45 | MUSK | 1.07959144 |
| 46 | NTRK3 | 1.04604199 |
| 47 | PRKAA1 | 1.00814382 |
| 48 | TYK2 | 0.98570098 |
| 49 | JAK2 | 0.96929203 |
| 50 | MAP3K4 | 0.96538999 |
| 51 | CAMK1G | 0.94851247 |
| 52 | MAPK13 | 0.91956249 |
| 53 | SGK494 | 0.87669325 |
| 54 | SGK223 | 0.87669325 |
| 55 | FGFR2 | 0.87579311 |
| 56 | TGFBR2 | 0.84669891 |
| 57 | KDR | 0.84152932 |
| 58 | FGFR1 | 0.82945557 |
| 59 | DYRK1B | 0.81474626 |
| 60 | WNK4 | 0.80681720 |
| 61 | RIPK1 | 0.80402831 |
| 62 | CDK6 | 0.78601423 |
| 63 | MTOR | 0.78245132 |
| 64 | EPHA2 | 0.77497650 |
| 65 | MET | 0.77020828 |
| 66 | MAP2K1 | 0.76937472 |
| 67 | LATS2 | 0.70734720 |
| 68 | PRKACG | 0.70295255 |
| 69 | MAP3K3 | 0.70184377 |
| 70 | JAK1 | 0.67931348 |
| 71 | PRKCE | 0.67355143 |
| 72 | GSK3A | 0.67209366 |
| 73 | PRKCZ | 0.66925323 |
| 74 | CSNK1D | 0.65619054 |
| 75 | EPHA3 | 0.65461533 |
| 76 | CSK | 0.64940383 |
| 77 | AKT3 | 0.64814993 |
| 78 | CDK4 | 0.64429632 |
| 79 | OXSR1 | 0.64046668 |
| 80 | DYRK2 | 0.63822019 |
| 81 | PRKG1 | 0.62899075 |
| 82 | PDK2 | 0.61557161 |
| 83 | NLK | 0.61503362 |
| 84 | PRKACA | 0.61395609 |
| 85 | ERBB2 | 0.60587981 |
| 86 | PDPK1 | 0.60410791 |
| 87 | PHKG2 | 0.60184096 |
| 88 | PHKG1 | 0.60184096 |
| 89 | MAP3K11 | 0.54746526 |
| 90 | STK16 | 0.54493380 |
| 91 | SGK2 | 0.53766024 |
| 92 | PTK2 | 0.53135096 |
| 93 | TIE1 | 0.52593327 |
| 94 | CAMK1 | 0.52335388 |
| 95 | MAP2K2 | 0.52103726 |
| 96 | MAPK4 | 0.51924873 |
| 97 | CSNK1E | 0.51701109 |
| 98 | TGFBR1 | 0.49662151 |
| 99 | PAK3 | 0.49329578 |
| 100 | MKNK2 | 0.49054937 |
| 101 | CSNK1G1 | 0.48742455 |
| 102 | MAPKAPK5 | 0.48198148 |
| 103 | MAP3K2 | 0.47287720 |
| 104 | MAP2K3 | 0.46773831 |
| 105 | FGFR3 | 0.46684312 |
| 106 | KSR2 | 0.46620418 |
| 107 | SGK1 | 0.45730254 |
| 108 | BRSK2 | 0.45685223 |
| 109 | ACVR1B | 0.43364135 |
| 110 | PRKCQ | 0.42918022 |
| 111 | IGF1R | 0.42859080 |
| 112 | CAMK2G | 0.42193811 |
| 113 | PRKACB | 0.41912940 |
| 114 | CHUK | 0.41739046 |
| 115 | MAP3K6 | 0.41737539 |
| 116 | NME1 | 0.39557954 |
| 117 | TRIM28 | 0.39217071 |
| 118 | PDGFRA | 0.39195148 |
| 119 | STK3 | 0.39136328 |
| 120 | GRK6 | 0.37991279 |
| 121 | MAP3K10 | 0.37338169 |
| 122 | MAP3K7 | 0.37233545 |
| 123 | RPS6KA3 | 0.35979571 |
| 124 | MARK1 | 0.35413065 |
| 125 | MAPK12 | 0.34869045 |
| 126 | PDK1 | 0.34492411 |
| 127 | EIF2AK3 | 0.32227992 |
| 128 | TBK1 | 0.31187571 |
| 129 | STK11 | 0.31094780 |
| 130 | IKBKB | 0.30980170 |
| 131 | IRAK1 | 0.30720766 |
| 132 | RPS6KA5 | 0.30538206 |
| 133 | PRKCA | 0.30292281 |
| 134 | MAP2K6 | 0.30029220 |
| 135 | ICK | 0.29323809 |
| 136 | TXK | 0.29026858 |
| 137 | TRPM7 | 0.28914784 |
| 138 | MAP3K5 | 0.27871786 |
| 139 | MAPK7 | 0.26015680 |
| 140 | RPS6KB1 | 0.25883308 |
| 141 | EIF2AK1 | 0.25335738 |
| 142 | SGK3 | 0.25198848 |
| 143 | ARAF | 0.25154401 |
| 144 | GRK1 | 0.23953080 |
| 145 | PRKCG | 0.23393793 |
| 146 | NEK1 | 0.23188455 |
| 147 | EPHB1 | 0.22227530 |
| 148 | MAP3K1 | 0.21795891 |
| 149 | RET | 0.21263466 |
| 150 | FER | 0.21065062 |
| 151 | MAPKAPK3 | 0.18543124 |
| 152 | BRAF | 0.18223631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.09552206 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.59603852 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.07062692 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.93923646 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.85710664 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.78884713 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.70660881 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.67173709 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.62537816 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.54265436 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.53298137 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.44486677 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.37570623 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.15534972 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.11802815 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.08017504 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.06558622 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.05799386 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.92251375 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83612969 |
| 21 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.76366544 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.75541371 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.74328076 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73493101 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.72709283 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.71584027 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.64089908 |
| 28 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.60885179 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.58326907 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.56199410 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.56063389 |
| 32 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.55604878 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.53875109 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.53157094 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.48674985 |
| 36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.47436970 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.47041199 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.46981589 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.46665812 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.42564702 |
| 41 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.39023253 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.37502486 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35385769 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.32926020 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32196731 |
| 46 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.29957645 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.26730910 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.26681588 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26052972 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23737311 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.18460898 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07609829 |
| 53 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.04789381 |
| 54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.04002294 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.00498899 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99017184 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.94061293 |
| 58 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.93947593 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90246654 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86872468 |
| 61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86774546 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.82378683 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81491004 |
| 64 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.78812209 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75257426 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73732878 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71366944 |
| 68 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.70782617 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67352741 |
| 70 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.63099841 |
| 71 | Phototransduction_Homo sapiens_hsa04744 | 0.57477422 |
| 72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57377912 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.57128107 |
| 74 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56197671 |
| 75 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53385962 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51781936 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44065332 |
| 78 | Mineral absorption_Homo sapiens_hsa04978 | 0.42137651 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41485625 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.40169851 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.37821211 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37443686 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35568590 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.35488480 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34975260 |
| 86 | RNA polymerase_Homo sapiens_hsa03020 | 0.33805371 |
| 87 | Taste transduction_Homo sapiens_hsa04742 | 0.32468889 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.31629541 |
| 89 | Nicotine addiction_Homo sapiens_hsa05033 | 0.28382000 |
| 90 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.26486585 |
| 91 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25828263 |
| 92 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.23828802 |
| 93 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.23503355 |
| 94 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.22539499 |
| 95 | Basal transcription factors_Homo sapiens_hsa03022 | 0.20899626 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20662006 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.17107857 |
| 98 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.13844819 |
| 99 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.11311809 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.06592091 |
| 101 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.05489509 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.00092376 |
| 103 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1743259 |
| 104 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.1739181 |
| 105 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1635563 |
| 106 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1508645 |
| 107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1419510 |
| 108 | Lysosome_Homo sapiens_hsa04142 | -0.1413463 |
| 109 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1407170 |
| 110 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1163673 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1136434 |
| 112 | Protein export_Homo sapiens_hsa03060 | -0.0810349 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0677769 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0672964 |
| 115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0436541 |
| 116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0364460 |
| 117 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0273650 |

